this impedes the onset of action of the drug
C., & Germani, A
We excluded 1) those with diagnoses of AF, atrial tachycardia, ventricular tachycardia, ventricular fibrillation, mechanical valve, hyperthyroidism, or mitral stenosis before or on the index date, 2) those with cardiac events (i.e., myocardial infarction, percutaneous intervention, valve/bypass surgery) in the preceding 3 months, 3) those currently receiving antiarrhythmic medications (e.g., amiodarone, dronedarone, flecainide, propafenone, or dofetilide) on the index date, 4) those who used insulin within one year prior or on the index date, and 5) those who do not have hemoglobin A1C (HbA1c) within one year prior or on the index date (eFigure 1)
12 mg was the maximum tested in the Jastreboff et al
Side Effects: Why Dose Strategy Matters GLP-1 medications can cause gastrointestinal side effects, especially during the first few weeks of treatment or after a dose increase
Contact your Medicaid managed care plan directly, visit your state Medicaid agencys website, or ask your pharmacist to run a coverage check
